Pulmonx Corp (LUNG) — Strategic Asset Allocation Index
Pulmonx Corp (LUNG) has a Strategic Asset Allocation Index of 0.0% as of December 2024. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $85.81 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See LUNG net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Pulmonx Corp Strategic Asset Allocation Index (2020–2024)
This chart shows how Pulmonx Corp's Strategic Asset Allocation Index has evolved across 5 annual periods from 2020 to 2024. As of December 2024, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $85.81 Million USD. For live market cap and overall valuation, see market value of Pulmonx Corp.
Annual Strategic Asset Allocation Index for Pulmonx Corp (2020–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Pulmonx Corp from 2020 to 2024, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See net assets of Pulmonx Corp for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 0.0% | $0.00 | $- | $0.00 | $85.81 Million | ▼ -12.2 pp |
| 2023 | 12.2% | $14.39 Million | $- | $14.39 Million | $118.31 Million | ▲ +4.9 pp |
| 2022 | 7.3% | $11.21 Million | $5.28 Million | $5.92 Million | $154.01 Million | ▼ -5.1 pp |
| 2021 | 12.3% | $23.83 Million | $12.89 Million | $10.94 Million | $193.24 Million | ▲ +7.7 pp |
| 2020 | 4.6% | $10.45 Million | $10.45 Million | $0.00 | $226.13 Million | — |